Why is Oruka Therapeutics, Inc. stock down today?
September 23, 2026
Oruka Therapeutics, Inc.
ORKA · NGM · USD
vs. prev. close $94.55
Last updated Sep 23, 2026 17:39
Intraday Chart — 5-min intervals
ORKA · less than a minute ago
Oruka Therapeutics, Inc. loses 7.28%: news, volume, and market context
Oruka Therapeutics, Inc. (ORKA) is tumbling at $87.67, down 7.28% from the previous close of $94.55. The broader market is under pressure, with S&P 500: -0.8%, Nasdaq: -1.2%, Dow Jones: -0.6%, Shanghai: -0.3%, Hang Seng: -0.8%.
Recent coverage is part of the setup, especially "Biotech Stocks Dive As Top 2% Names Take Hardest Hit" and "Oruka Therapeutics Says Psoriasis Drug Shows Deepening Efficacy", leaving sentiment around ORKA mixed.
This is market context, not financial advice.
Key Factors
Auto-generated analysis · Not financial advice

Biotech Stocks Dive As Top 2% Names Take Hardest Hit
Investor's Business Daily·about 1 hour agoneutral
Oruka Therapeutics Says Psoriasis Drug Shows Deepening Efficacy
Benzinga·about 4 hours agoneutral
Oruka Therapeutics Shares Fall 5% After Week 28 ORKA-001 Trial Data
InvestorsHub·about 5 hours agoneutralOruka Therapeutics Reports Deepening Responses for ORKA-001 Through Week 28
MT Newswires·about 6 hours agoneutral
Oruka Therapeutics Announces Positive Week 28 Data for ORKA-001 from the Ongoing EVERLAST-A Trial Showing Deepening of Responses Without Additional Dosing
GlobeNewswire·about 7 hours agoneutralOruka Therapeutics Insider Sold Shares Worth $936,417, According to a Recent SEC Filing
MT Newswires·2 days agoneutral
Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference
GlobeNewswire·14 days agoneutral
ORKA Stock Up More Than 60% in 3 Months: Here's What You Should Know
Zacks·26 days agoneutral
S&P 500
-0.76%
Nasdaq
-1.23%
Dow Jones
-0.59%
Shanghai
-0.34%
Hang Seng
-0.83%
Nikkei 225
+1.38%
FTSE 100
-0.03%
Nifty 50
+0.14%
DAX
-0.66%
OMX Stockholm
-0.57%
Search another stock